Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocort in severe inflamed atherosclerosis
NCT01601106Phase 2Unknown
- Sponsor
- University of Amsterdam
- Start
- Sep 2011
- Primary completion
- May 2013
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal prednisolone in atherosclerosis, sponsored by University of Amsterdam. Status: unknown.
02
Drugs
liposomal prednisolone
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT01601106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601106.